Transplant Diagnostics Market is expected to reach US$ 1,542.89 Million by 2027

Published Date: 23 Apr 2019

Report : Transplant Diagnostics Market to 2027- Global Analysis and Forecasts By Product & Services (Instruments, Reagents & Consumables, and Software & Services), Type (Solid Organ Transplantation, Soft Tissue Transplantation, and Stem Cell Transplantation), Technology (Molecular Assays and Non-Molecular Assays), Application (Diagnostic Applications and Research Applications), and End User (Hospitals & Transplant Centers, Research Laboratories & Academic Institutes, and Independent Reference Laboratories)

Transplant Diagnostics Market: Key Insights

According to our new research study on “Transplant Diagnostics Market Forecast to 2027 – Global Analysis – by Product & Services, Type, Technology, Application and Geography,” the global transplant diagnostics market size is expected to reach US$ 1,542.89 million by 2027 from US$ 789.88 million in 2018; it is estimated to grow at a CAGR of 7.9% during 2019–2027. The report highlights trends prevailing in the market and factors driving its growth. The transplant diagnostics market growth is attributed to rising need for organ transplantation and rising cell-based research activities. However, the limited number of donors for organ transplantation surgeries may hinder the growth of market.

 

North America is the largest market for transplant diagnostics with the US holding the largest market share followed by Canada. The market for transplant diagnostics in the US is expected to grow owing to the availability of advanced healthcare infrastructure, increasing number of transplant procedures as well as availability of skilled professionals. There has been a substantial increase in the number of transplant procedures conducted across the US. As per data published by US Department of Health & Human Services, there were around 36,527 organ transplants performed in the US in 2018. The country held an annual record for the sixth consecutive year, as per the Organ Procurement and Transplantation Network (OPTN). The rise in the number of organ transplant procedures along with the awareness regarding the importance of organ donation is expected to fuel growth of the market in the US during the forecast period.

 

The global transplant diagnostics market, based on product & services, is segmented into instruments, reagents & consumables and software & services. The reagents & consumables segment was the largest among the product & services subsegments in the transplant diagnostics market in 2018. However, the software & services segment is expected to witness growth in its demand at the fastest CAGR of 9.6% during 2019–2027. The global transplant diagnostics market, based on type, is segmented into solid organ transplantation, soft tissue transplantation, and stem cell transplantation. The solid organ transplantation segment held the largest share of the transplant diagnostics market in 2018 and is anticipated to continue to hold the largest market during the forecast period. The global transplant diagnostics market, based on technology, is segmented into molecular assays and non-molecular assays. In 2018, the molecular assays systems segment held a larger share of the market and is expected to witness growth in its demand at a faster CAGR of 9.5% during 2019–2027. The global transplant diagnostics market, based on application, is segmented into diagnostic applications and research applications. In 2018, the diagnostic applications segment held a larger share of the market and is expected to grow at a faster rate during 2019–2027.

 

Rising Need for the Organ Transplantation Fueling Transplant Diagnostics Market Growth

The organ transplantation surgeries are rising across the world. For instance, in Spain, approximately 5,260 transplant surgeries were performed, among which nearly 3,200 were kidney transplants and around 1,200 were liver transplant surgeries. The number of heart transplant surgeries were approximately 300 and lung were nearly 360. The public–private partnership in assistance with the transplant coordinators has enormously contributed to the improvement of organ transplantation. The developing and developed countries have shown significant number of organ transplantation surgeries. For instance, developing countries such as India and Singapore are emerging as medical tourism destinations in Asia Pacific. The countries are growing in terms of offering better and advanced medical treatments.

 

Transplant Diagnostics Market: Segmental Overview

Product and Services-Based Insights

The global transplant diagnostics market, based on product and services, is segmented into instruments, reagents & consumables, and software & services. The reagents & consumables segment held the largest share of the transplant diagnostics market in 2018. However, the software & services segment is expected to witness growth in its demand at the fastest CAGR of 9.6% during 2019–2027.

 

Type-Based Insights

The global transplant diagnostics market, based on type, is segmented into solid organ transplantation, soft tissue transplantation, and stem cell transplantation. The solid organ transplantation segment held the largest share of the transplant diagnostics market in 2018 and is anticipated to hold the largest market size during the forecast period.

 

Technology-Based Insights

The global transplant diagnostics market, based on technology, is segmented into molecular assays and non-molecular assays. In 2018, the molecular assays systems segment held a larger share of the market and is expected to witness growth in its demand at a faster CAGR of 9.5% during 2019–2027.

 

Application-Based Insights

The global transplant diagnostics market, based on application, is segmented into diagnostic applications and research applications. In 2018, the diagnostic applications segment held a larger share and is expected to grow at a faster rate during the coming years.

 

Transplant Diagnostics Market: Competitive Landscape and Key Developments

Bio-Rad Laboratories; Biomerieux SA; Illumina SA; Thermo Fisher Scientific, Inc; Qiagen N.V; F. Hoffmann-La Roche LTD.; Hologic Inc.; Luminex Corporation; Omixon Inc.; and Abbott are among the leading companies in the transplant diagnostics market. The transplant diagnostics market share is anticipated to flourish with the development of new innovative products by market players.

  • In April 2018, Qiagen launched QIAstat-Dxâ in Europe. The product launched has played an important role in oncology or transplantation surgeries, which improved treatment decisions.
  • In April 2017, One Lambda announced the availability of the FDA approved and CE marked LAB Screen Multi screening kit for detecting HNA-3 and HLA. Additional benefits of the product include processing up to 96 samples in under 4 hours.

Contact Us
Contact Person: Sameer Joshi 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com
Download Free PDF Brochure